Recent Headlines
Within Pharmaceuticals
Huntington Study Group Announces New CEO
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive... - August 20, 2024 - Huntington Study Group
Hemanext Inc. Announces Completion of Cancer and Burn Safety Study, a Significant Milestone for the Hemanext ONE® Innovative Red Blood Cell Processing and Storage System
The post-market clinical study in Bergen, Norway, that was designed to assess the safety of transfusing hypoxic red blood cells (RBCs) in patients with acute burns and hematological malignancies, has been completed. - August 20, 2024 - Hemanext
Chartwell Launches New Ambulatory Infusion Suite in Oakdale, PA
Chartwell Pennsylvania, LP is proud to announce the launch of a new, nine-chair infusion suite, located in our Oakdale, PA headquarters. CHOICE by Chartwell provides a new alternative for patients to choose where they would like to receive their infusion therapy: at home, or at the new infusion Suite, located just minutes from Robinson Township and Pittsburgh, PA. The suite provides additional options for patients beyond physician offices or at their local hospital. - August 16, 2024 - Chartwell Pennslyvania, LP
VitaMist® Announces Exciting Competition: Win a Year’s Supply of Vitamins for You and a Friend
VitaMist®, a leader in Oral Spray Vitamins and Supplements, is thrilled to announce an exciting new competition offering participants the chance to win a year’s supply of vitamins for both themselves and a friend. - August 16, 2024 - VitaMist
Guides Collective Steps in Where Traditional Therapies have Failed with a Concierge Service to Match Seekers with Psychedelic Guides
Guides Collective launches psychedelic concierge service poised to become the "BetterHelp" of the psychedelic space. With over 600+ qualified psychedelic guides in their network, they work with you to find a psychedelic modality catered to a persons specific needs and desired outcome. - August 14, 2024 - Guides Collective
Evolution Analytics Expands with New Office in Durham, NC to Support Growing Demand for AI and Data Consulting Services
Strategic Expansion to Support Growing Client Demand and Leverage Top Tech Talent in the Raleigh/Durham Area - August 12, 2024 - Evolution Analytics
Californians Reject Board of Pharmacy’s Proposed Restrictions on Essential Alternative Medicines
Californians fight back against the Board of Pharmacy's proposed regulations that would severely restrict – and in many cases end – access to widely used sterile compounds like methylcobalamin (vitamin B12), glutathione, and NAD, easily accessible and legal in all 49 other United States. The Stop The BOP movement was formed in response, rallying significant public support to preserve access to these essential treatments. - August 08, 2024 - Stop The BOP
Parvus Therapeutics Announces Leadership Appointments to Support Development from Preclinical Into Clinical
New Positions Enhance Parvus Capability to Execute the Translation of Multiple Drug Candidates into the Clinic. - August 06, 2024 - Parvus Therapeutics U.S., Inc.
Pharma Lessons is Getting Ready for the Adoption of ICH E6 (R3)
In May 2023, the International Council for Harmonisation (ICH) released the third revision of the Good Clinical Practice E6 guidelines, replacing the E6 (R2) released in 2016. Currently, the document is published for public consultation. The purpose of this revision is to modernize the way... - August 06, 2024 - Pharma Lessons
Minus K Technology Announces Its Ninth Educational Giveaway of Vibration Isolators to U.S. Colleges and Universities
Minus K Technology announces its Educational Giveaway of Vibrations Isolators to U.S. Colleges and Universities. - August 05, 2024 - Minus K Technology Inc.
Creative Biolabs Spearheads Innovative Live Biotherapeutics Against Gut Diseases
Creative Biolabs introduces innovative solutions for live biotherapeutics to empower scientists and pharmaceutical companies in their quest for groundbreaking therapies against gut diseases. - August 03, 2024 - Creative Biolabs
Silver Scott Mines, Inc. Signs Letter of Intent to Acquire Innovative, Patented Non-Invasive Brain Treatment Technology
Silver Scott Mines will be acquiring the assets of AddBrain, Inc.’s technology. It has been used to treat Huntington’s Disease, Parkinson’s and Suicidal Depression with excellent results. There are ongoing clinical trials in Canada. - August 02, 2024 - Silver Scott Mines, Inc.
GENINVO, a Leading Provider of Innovations in Life Science Announced the Offering of Its On-Demand Service/Tool: DocQC
GENINVO has been working towards automating healthcare industry and contributing to faster drug discovery. GENINVO target to bring innovations as technologies, to automate the traditional and time-consuming process of Medical Writing. One example being, automating the process of clinical and... - August 02, 2024 - GenInvo, Inc.
Parvus Therapeutics Has Received Orphan Drug Designation for Primary Biliary Cholangitis and Human Research Ethics Committee Approval to Begin Clinical Testing
Parvus Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to PVT201 for the treatment of Primary Biliary Cholangitis (PBC) and PVT201 has obtained Australian Human Research Ethics Committee (HREC) approval to initiate a first-in-human... - July 29, 2024 - Parvus Therapeutics U.S., Inc.
Edison Agrosciences Announces $600,000 Seed Financing Round and Addition of Industry Veteran Tom Marsh to Board of Directors
Edison Agrosciences, an industrial biomaterials company developing a sustainable domestic source of natural rubber from sunflowers, today announced the closing of a $600,000 seed financing. - July 26, 2024 - Edison Agrosciences
Leap Years®: Supports Age-Related Cognitive Decline in Dogs and Quality Time Together with Owners Through NAD+ Enrichment
Animal Biosciences Announces Peer-Reviewed Publication of a Clinical Trial to Evaluate the Slowing of Age-Related Signs in Dogs. After five years of development, clinical results are published regarding senior dog aging in a rigorous, placebo-controlled trial performed at a North Carolina State University College of Veterinary Medicine. - July 23, 2024 - Leap Years
U.S. Precision Medicine, Inc. Signs MOU to Deploy microNeb’s VIGIL Series Inhaler Technology to Enhance Absorption of Its New Drug Candidate in IND Process
U.S. Precision Medicine, Inc. (USPM) has signed a Memorandum of Understanding (MOU) to deploy microNeb's advanced inhaler technology to expedite the uptake of its new cancer drug candidate currently in the Investigational New Drug (IND) process. - July 16, 2024 - microNeb, Inc.
MC4R Agonist Drug Candidates Demonstrate Potential to Transform GLP1 Obesity Therapy
Courage Therapeutics announced new evidence of synergy between MC4R agonists and GLP1RA drugs in a paper published in the Journal of Clinical Investigation led by co-founder Dr. Roger Cone. The company has completed a drug discovery campaign to invent a best in class portfolio of MC4R agonists for obesity in order to leverage the synergy. Potential combinations with drugs such as Ozempic and Mounjaro could improve side effects such as nausea and GI discomfort while driving increased weight loss. - July 16, 2024 - Courage Therapeutics
SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr. Donna Wilcock, to Its Scientific Advisory Board
SYNAPS Dx welcomes Dr. Donna M. Wilcock, a leading Alzheimer's researcher, to its Scientific Advisory Board. Dr. Wilcock's expertise in neuroinflammation and vascular cognitive impairment will support the advancement of the DISCERN™ diagnostic test for Alzheimer's disease. This addition reinforces SYNAPS Dx’s commitment to pioneering accurate, minimally invasive diagnostics for Alzheimer's. For more info, visit SYNAPS Dx's website. - July 15, 2024 - SynapsDx
Huntington Study Group Announces Launch of LEAD-HD Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) today announce the release of their newest Patient Reported Outcomes (PRO) study, LEAD-HD. This observational study was developed collaboratively with the University of Rochester Center for Health +... - July 15, 2024 - Huntington Study Group
GDP Training Course is Now Ready and Free
Pharma Lessons’ new GDP training is finally out. It covers the guidelines for wholesale distribution of medicinal products as an important part of the supply chain management. The course is a summary of the most recent GDP (Good Distribution Practice) guidelines based on Articles 84 and... - July 15, 2024 - Pharma Lessons
NuvOx Pharma LLC Announces Authorization of ARDS Trial from Health Canada
NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND: novEl oXygen ThErapeutic NanO2 for mild respiratory distress in Phase Ib and ARDS in Phase II Trials. Evan Unger, MD, CEO of NuvOx, said, “Acute Respiratory Distress... - July 12, 2024 - NuvOx Therapeutics
LGBTQ+ Screenplay Shining Light on Opioid Crisis Unveils Title & New Website
Multi-award winning film script has a new title and a new website to promote the message of hope. Inspired by true events, the screenplay depicts the harsh realities of opioid addiction and the challenging road to recovery those struggling must face. - July 02, 2024 - Worthy
igus® Presents a Unique 4-Year Guarantee for Their Products
Even greater operational reliability and sustainability thanks to billions of test cycles in their in-house laboratory. - June 28, 2024 - igus Singapore Pte Ltd
Abel Womack CEO Announces His Retirement and Successor
After 50 years with Abel Womack, John Croce, CEO retires. - June 27, 2024 - Abel Womack Inc
Daicel Arbor Biosciences Launches New myTXTL® Kits to Accelerate Protein Expression
Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering. These powerful new kits include the myTXTL Pro Kit and the myTXTL Antibody/DS... - June 27, 2024 - Daicel Arbor Biosciences
Natural Scientific Launches Amazon Storefront to Revolutionize Nutritional Supplement Market
Privately-owned American company introduces a new range of natural, filler and additive-free vitamins and minerals. - June 26, 2024 - Natural Scientific Labs LLC
SYNAPS Dx Announces Expansion to New, State-of-the-Art Facility
SYNAPS Dx has moved to a new, state-of-the-art facility in Rockville, MD, to meet growing demand and enhance patient care. The larger space and advanced infrastructure will support more diagnostic samples and ensure timely, accurate Alzheimer's and dementia diagnoses. Fully qualified for high-complexity clinical lab testing, the facility boosts diagnostic capabilities. The expansion will also advance the DISCERN™ test, a minimally invasive tool distinguishing Alzheimer's from other dementias. - June 26, 2024 - SynapsDx
Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science
Cambridge Polymer Group (CPG) announced a new leadership structure to better support clients in developing innovative products. CPG is creating a new five-person senior management team with deep materials science expertise, which will allow for closer collaboration with clients on complex projects. Dr. Gavin Braithwaite will be the new CEO and Dr. Stephen Spiegelberg will move to the new role of Chief Scientific Officer (CSO). - June 23, 2024 - Cambridge Polymer Group
I Holland Launches Tooling Safe Disposal & Recycling Service
I Holland, has launched its new Safe Disposal &Recycling Service. This valuable service is designed to ensure the safe, secure, and environmentally responsible destruction of obsolete or worn-out tooling, enhancing both the integrity and sustainability of pharmaceutical manufacturing. Their... - June 23, 2024 - I Holland Ltd.
VITAMIST® Unveils New Enhanced Website for Premium Vitamin Oral Sprays
VITAMIST®, inventor of vitamin oral sprays, is excited to announce the launch of its newly redesigned website, www.vitamist.com. This significant update underscores VITAMIST's commitment to providing high-quality, science-backed vitamin solutions. - June 13, 2024 - VitaMist
KIRON.AI Launches Book “NEOBANK Navigating the Future of Banking” by Author and Bank Owner Ronald Ingram
KIRON.AI, a Henderson, Nevada-based AI Health & Wealth company launches “NEOBANK Navigating the Future of Banking,” a groundbreaking book exposing the history and predicting the future of banking from author Ronald Ingram’s perspective as a bank owner, historian, futurist and polymath. The company KIRON.AI employs artificial intelligence (AI) to discover, uncover, develop and deploy protocols, tools and information to enhance human wealth and health preservation and generation. - June 11, 2024 - Kiron.AI
Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.
New publication shows groundbreaking result in FOXG1 AAV9 gene therapy studies, rescuing structural brain abnormalities caused by the pediatric rare disease, FOXG1 syndrome. This paper summarizing work done by the FOXG1 Research Center, led by Dr. Soo-Kyung Lee, Dr. Jae W. Lee and Dr. Kathrin Meyer (responsible for the SMA gene therapy), shows remarkable rescue of brain abnormalities using AAV9 gene therapy. - June 10, 2024 - FOXG1 Research Foundation
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com. PCRassays.com offers more than 200 qPCR-based assays for infectious diseases, over 50 of... - June 07, 2024 - Cayman Chemical Company
FlowSense: Affordable Antibiotic Testing to Transform the Honey Industry from Biorex Food Diagnostics
Biorex Food Diagnostics announced today the launch of its cutting-edge FlowSense product line, with the first phase designed specifically for the honey industry. The new FlowSense test products introduce a comprehensive range of antibiotic test panels, providing honey producers with an innovative... - June 07, 2024 - Biorex Food Diagnostics
Megalabs Acquires Majority Interest and Control of DS Laboratories
Megalabs, a leading pharmaceutical company, has acquired majority interest and control of DS Laboratories (“DS Labs”), a leading dermatology company focused on science backed hair care across 50+ countries. This strategic move enhances Megalabs' position in the global dermatology market and the US. - May 31, 2024 - Megalabs
LGBTQ Screenplay Secures Oscar-Nominated Director Strengthening the Team Supporting the Films Message
Following its fourth film festival win, the writer of "You Are What You Love" recently announced the addition of Bradley Raymond to the team working to get the story to screen. The sapphic drama is based on true events about a young lesbian struggling with opioid addiction and sheds much... - May 30, 2024 - Worthy
Sosemo LLC Awarded on the Financial Times Americas’ Fastest Growing Companies 2024 List
Sosemo LLC Awarded on the Financial Times Americas’ Fastest Growing Companies 2024 List Sosemo LLC has been awarded on the Financial Times list of The Americas’ Fastest Growing Companies 2024. This prestigious award is presented by the Financial Times and Statista Inc., the... - May 30, 2024 - Sosemo
New GVP Training with Certificate
Pharma Lessons has launched a new Good Pharmacovigilance Practice Training with certificate. The training has been developed from scratch and is quite different from the free GVP course that the company currently offers on the corporate website. It is a brand new product that features new content,... - May 29, 2024 - Pharma Lessons
Jusha International and Dextro Imaging Form Strategic Partnership
Jusha International Collaborates with Dextro Imaging Specialists, Revolutionizing Radiology with Lower Costs and Enhanced Quality - May 28, 2024 - Pacs Harmony
Evolution Analytics Awarded “Most Innovative Data & Analytics Consultancy” by Acquisition International
Evolution Analytics is Recognized for Pioneering Excellence in Data Solutions and Analytics Consulting Services - May 24, 2024 - Evolution Analytics
Creative Biolabs Opens Applications for the 2024 Scholarship Program
Creative Biolabs, a leading CRO, is proud to announce the opening of applications for its 2024 scholarship program. This initiative aims to provide financial assistance to students within the biotechnology industry, supporting their academic pursuits and research endeavors. - May 19, 2024 - Creative Biolabs
GENINVO Launches Its Latest Offering – DocWrightAI
GENINVO, a leading provider of life science products and business solutions announced the launch of its new, on-demand service: DocWrightAI. GENINVO understands the various challenges in generating clinical documents. The time taken to draft clinical documents with accuracy and compliance has... - May 18, 2024 - GenInvo, Inc.
Snova's Halal Extract Wins Its Third Consecutive Gold at the Monde Selection
Snova’s Halal Extract has won the gold award for its third consecutive year at the Monde Selection 2024. ・Snova’s Halal Extract is a skincare product manufactured in accordance with Islamic law (Halal). In Islam, certain ingredients and manufacturing processes are prohibited, so... - May 15, 2024 - Snova Co.
Dr. Pompa Explores the Hidden Risks of Root Canals
Dr. Pompa discusses the hidden risks of root canals in his latest health coaching initiative, revealing that often these procedures may carry infections that affect surrounding tissues. Despite meticulous care, root canals inherently possess risks, suggesting that sometimes avoiding the procedure might be safer. This exploration underscores the importance of careful decision-making and consultation in dental health and wellness. - May 10, 2024 - Pompa Program
New GMP Training with Certificate from Pharma Lessons
Pharma Lessons has launched a brand new Good Manufacturing Practice Training. The new course covers the latest GMP principles and guidelines and is a beautifully designed interactive product that provides both fundamental knowledge and a pleasant experience. The materials are split into 8 separate... - May 09, 2024 - Pharma Lessons
SeabuckWonders Unveils Functional New Product for Women
Fem-Omega 7 Makes its Debut as Ultimate Supplement for Female Dryness. - May 08, 2024 - SeabuckWonders
Wiser Wellness Awarded Prestigious 2023 BBB Spark Award for Exceptional Leadership and Service in Telemedicine
Wiser Wellness is proud to announce that it has won the prestigious 2023 BBB Spark Award for outstanding leadership and service in telemedicine. This honor highlights Wiser Wellness's commitment to integrity, innovation, and community engagement in healthcare. For more on this transformative force in telemedicine, contact Hi@wiserwellness.com. - May 07, 2024 - Wiser Wellness
Novugen Launches Pazopanib Tablets, 200mg, in the U.S. Following ANDA Approval by USFDA
Novugen has launched Pazopanib tablets, 200mg, in the U.S. after receiving ANDA approval from USFDA on April 23, 2024. This significant milestone demonstrates Novugen's continued growth in the U.S. pharmaceutical market with a complex anticancer drug, the generic equivalent of Votrient, used to treat advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS). - May 07, 2024 - Novugen
Limited Opportunity: Enroll in Ales for ALS 2024 Today, Secure Your Spot as Part of a Growing National Movement
Ales for ALS invites brewers to craft distinctive and flavorful beers using a custom hop blend generously donated by Yakima Chief Hops. In exchange, participating brewers pledge to donate $1 for every pint sold, directly contributing to groundbreaking ALS research at the ALS Therapy Development Institute (ALS TDI). - May 04, 2024 - ALS Therapy Development Institute